baber/WOPTO huggingface dataset:
Patent NZ-584318-A (NZ)
Title: Tie for identification ring with a locking member
Inventor: LEGAT JEAN-JACQUES
IPC: A01K11/00
Filed: 2008-12-11
Abstract: A tie comprising a strap 1 extending along a first longitudinal axis between two end parts fitted respectively with a female part 3 and a male part 5, of a fastening system and a locking member of the male part 5 in the female part 3 when the male part 5 is inserted in the female part 3. The locking member comprises a strip 6 and a slot crossing the male part 5 of the fastening system. The strip 6 is designed to be inserted along a second axis approximately perpendicular to the longitudinal axis. A locking mechanism of the strip 6 in slot is provided in such a way as to prevent sliding of the strip 6 in the slot in an opposite direction according to the second axis after the strip 6 has crossed a certain insertion position in the slot along the axis of insertion. The locking mechanism comprises notches arranged along a first end part of the strip 6, a lock in which the notches of the strip 6 are inserted, and which is placed on the strap 1 laterally on one side of the slit in the male part 5 of the fastening system and a collar in which the strap 1 is inserted and which is placed on the strap 1 laterally on the other side of the slit in alignment with the lock and the slit along the second axis and a first protuberance 5 placed at a second end part on the strip 6 so as to abut against the collar when the strip 6 crosses the collar and the slit and so that the notches of the strip 6 are inserted in the lock.
Patent NZ-585366-A (NZ)
Title: Wastewater treatment process and plant comprising controlling the dissolved oxygen concentration
Inventor: HOYLAND GARRY
IPC: C02F3/00
Filed: 2008-11-14
Abstract: Disclosed herein is a process for treating wastewater comprising: a) a contact step, wherein wastewater contacts bacteria retained on a support surface and the dissolved oxygen concentration of the wastewater is maintained at 2.0mg/l or less; b) an aeration step, wherein gas is passed through wastewater that has passed through the contact step and the dissolved oxygen concentration of the wastewater is reduced as the wastewater passes through the aeration step; c) a sedimentation step, wherein wastewater that has passed through the aeration step is substantially separated into treated water and sludge; and d) a sludge recycling step, wherein sludge from the sedimentation step is passed to the contact step. Also disclosed is a unit for treating wastewater, wherein the unit comprises: (a) a contact tank, which includes a support surface on which bacteria are retained and that is positioned so as to come into contact with wastewater retained in the contact tank; (b) an aeration tank that includes means for passing gas through wastewater retained within the aeration tank; (c) a conduit provided between the contact tank and aeration tank and through which wastewater can pass from the contact tank to the aeration tank; (d) a sedimentation tank; (e) a conduit provided between the aeration tank and the sedimentation tank and through which wastewater can pass from the aeration tank to the sedimentation tank; (f) a conduit provided between the sedimentation tank and the contact tank and through which sediment can pass from the sedimentation tank to the contact tank; and (g) a wastewater dissolved oxygen concentration control means capable of maintaining the dissolved concentration of wastewater retained in the contact tank at 2.0 mg/I or less and capable of reducing the dissolved oxygen concentration of wastewater as it passes through the aeration tank or tanks.
Patent NZ-586053-A (NZ)
Title: Anti-vegf antibody compositions and methods
Inventor: KAVLIE ANITA
IPC: A61K39/395
Filed: 2008-11-07
Abstract: Provided is an isolated antibody that binds to VEGF and that comprises at least one heavy chain variable region that comprises three CDRs with defined sequences or their variants containing conservative amino acid substitutions. The antibodies can be used to treat various diseases including cancer, arthritis and psoriasis, by inhibiting angiogenesis or lymphangiogenesis.
Patent NZ-586094-A (NZ)
Title: Proline analogs as ligands for cannabinoid receptors for the treatment of pain
Inventor: SHAO BIN
IPC: A61K31/381
Filed: 2009-01-08
Abstract: Disclosed are proline sulfamide compounds represented by general formula (Ia) and I(b). The compounds are used as cannabinoid receptors for the treatment of pain.
Patent NZ-587186-A (NZ)
Title: Multi-step method for producing algae products
Inventor: JU LU-KWANG
IPC: C02F3/32
Filed: 2008-12-30
Abstract: Disclosed is a multi-step method for producing an algae product from waste water treatment including: a waste consumption step including, combining, in a first vessel, organic waste products and phagotrophic-algae-consumable microorganisms capable of consuming said organic waste products, and allowing said phagotropic-algae-consumable microorganisms to consume said organic waste products to thereby grow said phagotrophic-algae-consumable microorganisms; and transferring said phagotrophic-algae-consumable microorganisms to a second vessel; and a phagotrophic-algae-consumable microorganism consumption step carried out after said waste consumption step, said phagotrophic-algae-consumable microorganism step including: adding phagotrophic algae to said second vessel, allowing said phagotrophic algae to consume said phagotrophic-algae-consumable microorganisms and thereby grow said phagotrophic algae; collecting a desired algae product from said phagotrophic algae.
Patent NZ-588222-A (NZ)
Title: Determine pith center of annual rings of wood by calculating normals to tangents of rings
Inventor: HIRAOKA NORIYUKI
IPC: G06K9/00
Filed: 2010-09-27
Abstract: To improve operational efficiency of peeling a wood block by automatically acquiring the centre of annual rings of the wood block, the normal line direction of an annual ring 44 is acquired in a seek filter 42 set on an image obtained by photographing a block end of the wood block. Movement path lines 43 are respectively sought as the seek filter 42 is moved in the normal line direction toward the annual ring centre 45 from a plurality of seek starting points 41 set on an outer peripheral edge of the block end and the annual ring centre 45 is detected based on the intersection point of the plurality of movement path lines 43. Accordingly, the annual ring centre 45 is automatically detected by an imaging process performed by an image processing processor 10, so that a workman is not required to observe the annual ring centre 45 with the unaided eye each time when a wood block is mounted on a veneer lathe.
Patent NZ-590043-A (NZ)
Title: Substituted pyrimidone derivatives
Inventor: SAADY MOURAD
IPC: A61K31/519
Filed: 2009-06-25
Abstract: Disclosed are 2-pyridin-4-yl-4H-pyrido[1,2-a]pyrimidin-4-one derivatives as represented by the general formula (I), wherein R1 represents a 4-pyridine ring; R2 and R3 represent a hydrogen atom; R4 is selected from hydrogen, halo or optionally substituted phenyl; R5 is selected from hydrogen, alkyl, 4-pyridyl, phenyl each of which may be optionally substituted; R6 is selected from hydrogen atom, alkyl group, benzyloxy, phenyl or alkyl (each of which may be optionally substituted); in form of a free base or of an addition salt with an acid, or a solvate thereof, or a hydrate thereof; with the proviso that when R4 and R5 represent a hydrogen atom, R6 is not methyl or benzyl. Of particular importance are the compounds 2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 7-phenyl-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 8,9-dimethyl-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 8-phenyl-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 2,8-di-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 9-benzyloxy-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 9-[2-(2-methoxy-phenyl)-ethyl]-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 2-pyridin-4-yl-9-(2-o-tolyl-ethyl)-pyrido[1,2-a]pyrimidin-4-one, 9-(3-phenyl-propyI)-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 9-[2-(2,4-difluoro-phenyl)-ethyl]-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one, 9-[2-(2-fluoro-phenyl)-ethyl]-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one and 9-[3-(2-fluoro-phenyl)-propyl]-2-pyridin-4-yl-pyrido[1,2-a]pyrimidin-4-one. Further disclosed is a medicament which comprising as an active ingredient a GSK3b inhibitor substance as defined above, for preventive and/or therapeutic treatment of a condition such as Alzheimer's disease, Parkinson's disease, tauopathies, vascular dementia, acute stroke, traumatic injuries, cerebrovascular accidents, brain cord trauma, spinal cord trauma, peripheral neuropathies, retinopathies or glaucoma, non-insulin dependent diabetes, obesity, manic depressive illness, schizophrenia, alopecia, cancers, parenchymal renal diseases, muscle atrophy, breast cancer, non-small cell lung carcinoma, thyroid cancer, T or B-cell leukemia, virus-induced tumors, malaria, bone diseases or Pemphigus vulgaris.
Patent NZ-592931-A (NZ)
Title: Method of moulding a wind turbine blade
Inventor: SCHIBSBYE KARSTEN
IPC: B29C41/00
Filed: 2011-05-18
Abstract: A method of moulding a wind turbine blade 10 in a mould, comprises the steps of applying a sheet of film 4 to an inside surface of the mould 2, where an outside surface of the film 4 comprises a relief structure and/or the inside surface of the mould 2 comprises at least one channel 23 to facilitate the removal of air from between the film 4 and the inside surface of the mould 2, assembling component layers for the wind turbine blade 10 on the film 4, performing curing steps to harden the component layers, and subsequently removing the cured wind turbine blade 10 from the mould 2.
Patent NZ-593030-A (NZ)
Title: Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
Inventor: ARTMAN III GERALD DAVID
IPC: A61K31/404
Filed: 2009-12-07
Abstract: 593030 Disclosed is a amide and pyrimidine substituted indole of formula (III) where the substituents are as disclosed in the specification. An example of a compound of formula (III) is N-(5-cyclopropyl-1-ethyl-1H-pyrazol-3-yl)-5-(2-( (methylamino)methyl)pyrimidin-4-yloxy)-1H-indole-1-carboxamide. Also disclosed are pharmaceutical combinations comprising a compound of formula (III) the use of a compound of formula (III) in the manufacture of a medicament and a method of treating a VEGF-R mediated disease in a non-human animal by administering a compound of formula (III).
Patent NZ-593833-A (NZ)
Title: Extended recombinant polypeptides and compositions comprising same
Inventor: SCHELLENBERGER VOLKER
IPC: C07K1/00
Filed: 2010-02-03
Abstract: 593833 Disclosed is an extended recombinant polypeptide (XTEN) comprising greater than about 36 to about 3000 amino acid residues, wherein the XTEN is characterized in that: (a) the sum of glycine (G), alanine (A), serine (S), threonine (T), glutamate (E) and proline (P) residues constitutes more than about 80% of the total amino acid sequence of the XTEN; (b) the XTEN sequence is substantially non-repetitivesuch that (i) the XTEN contains no three contiguous amino acids that are identical unless the amino acids are serine; (ii) at least about 80% of the XTEN sequence consists of non-overlapping sequence motifs, each of the sequence motifs comprising about 9 to about 14 amino acid residues consisting of four to six types of amino acids selected from glycine (G), alanine (A), serine (S), threonine (T), glutamate (E) and proline (P), wherein any two contiguous amino acid residues do not occur more than twice in each of the non-overlapping sequence motifs; or (iii) the XTEN sequence has a subsequence score of less than 10; (c) the XTEN sequence lacks a predicted T-cell epitope when analyzed by TEPITOPE algorithm, wherein the TEPITOPE algorithm prediction for epitopes within the XTEN sequence is based on a score of -9 or greater. (d) the XTEN sequence has greater than 90% random coil formation as determined by GOR algorithm; and (e) the XTEN sequence has less than 2% alpha helices and 2% beta-sheets as determined by Chou-Fasman algorithm.
Patent NZ-593994-A (NZ)
Title: Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators
Inventor: KUHNERT SVEN
IPC: A61K31/472
Filed: 2009-12-16
Abstract: Disclosed is a substituted tetrahydroisoquinolinyl-4-oxobutyric acid amide of formula (1) in the form of the free compound or a salt of a physiologically compatible acid or base, wherein the substituents are as described within the specification. Examples of a compound of formula (1) includes 4-oxo-4-(1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)-N-(3-(trifluoromethyl)benzyl)butyric acid amide. Further disclosed is a medicinal product containing at least one compound of formula (1) in the form of an individual stereoisomer or a mixture thereof, the free compound and/or a physiologically compatible salt thereof, and optionally suitable additives and/or auxillary substances and/or further active ingredients. Also disclosed is the use of a compound of formula (1) in the preparation of a medicinal product for the treatment of pain, epilepsy, urinary incontinence, anxiety states, dependency, mania, bipolar disorders, migraine, cognitive diseases, and/or dystonia-associated dyskinesia.
Patent NZ-597866-A (NZ)
Title: Therapeutic lactams
Inventor: BURK ROBERT M
IPC: A61K31/4015
Filed: 2007-08-09
Abstract: ABSTRACT - 597866 The disclosure relates to a compound having a structural formula shown herein, the variables shown in the formula are as defined in the specification. These compounds are suitable for use in the manufacture of a medicament for the treatment of glaucoma or ocular hypertension in a mammal.
Patent NZ-600178-A (NZ)
Title: Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
Inventor: SCHRIMPF MICHAEL R
IPC: A61K31/433
Filed: 2007-11-06
Abstract: 600178 Disclosed are azaadamantane derivatives of formula (I) wherein L1 is –O- or –NRa-; A is – Ar2-L2-Ar3; wherein Ar2 is a 5 or 6-membered monocyclic heteroaryl and Ar3 is heteroaryl and the substituents are further defined within the specification. Examples of such compounds include (4s)-4-[6-(1H-indol-5-yl)pyridazin-3-yloxy]-1-azatricyclo[3.3.1.13,7]decane, (4s)-4- [5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-yloxy]-1-azatricyclo[3.3.1.13,7]decane and (4s)-4-[5-(1H-indol-5-yl)-thiazol-2-yloxy]-1-azatricyclo[3.3.1.13,7]decane. Also disclosed are N-borane and N-oxide complexes of the claimed compounds, processes for the preparation of the compounds of the invention, compositions comprising said compounds and uses thereof. The compounds are useful as nicotinic acetylcholine receptor ligands and are therefore useful in the treatment of conditions or disorders such as attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease (AD), mild cognitive impairment, schizophrenia and age-associated memory impairment.
Patent NZ-603364-A (NZ)
Title: Inhibitors of arginase and their therapeutic applications
Inventor: RYDER Todd
IPC: C07F5/02
Filed: 2011-04-20
Abstract: Disclosed are boron amine compounds according to Formula I and Formula II are potent inhibitors of Arginase I and II activity : Formule (I), (II) where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. Also disclosed are pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity. Examples of the compounds are: 2-amino-6-borono-2-(5’-Trifluoromethyl-3,4,5,6-tetrahydro-2-H-[1,2’]bipyridinyl-4-yl)-hexanoic acid hydrochloride; 2-amino-6-borono-2-[(4-Trifluoromethyl-pyrimidin-2yl)piperidin-4-yl)-hexanoic acid hydrochloride; (R)-2-amino-6-borono-2-(2-((S)-2-(methoxymethyl)pyrrolidin-1-yl)ethyl)hexanoic acid dihydrochloride and (R/S)-1-[(3-Amino-7-borono-3-carboxy)-heptyl)piperidine-4-carboxylic acid dihydrochloride.
Patent NZ-607488-A (NZ)
Title: A wirelessly rechargeable battery and power transmitter
Inventor: ROBERTSON DANIEL
IPC: H01M50/204
Filed: 2010-11-16
Abstract: Disclosed is a wirelessly rechargeable battery. The battery is comprised of an elongate battery casing (formed from 2 and 3). Within the casing (2 and 3) are a rechargeable storage device (4), one or more power receiving coils (5, 6) and a charging circuit (1). The coils (5, 6) are disposed on a ferrite core (7). The charging circuit (1) controls the supply of power from the coils (5, 6) to the storage device (4).
Patent NZ-610563-A (NZ)
Title: Multiuser scheduling for radio resource allocation
Inventor: SMITH PETER JEFFREY
IPC: H04W72/00
Filed: 2012-05-11
Abstract: Disclosed is a method of scheduling terminals in a wireless communication system. The method includes determining average power received from a plurality of terminals (T1, T2) at a plurality of base stations (B1, B2, B3). A metric is determined for each terminal (T1, T2) based on the average powers and a group of terminals are determined to each have an acceptable metric. Finally, the group of terminals is scheduled for simultaneous transmission in a time or frequency interval.
Patent NZ-610576-A (NZ)
Title: Coating compositions with anticorrosion properties
Inventor: FOSCANTE RAYMOND E
IPC: C09D7/48
Filed: 2011-10-14
Abstract: The disclosure relates to an anticorrosive coating composition comprising: a binding polymer selected from the group consisting of solvent-borne polymers, water-borne polymers and combinations thereof; an aluminum phosphate corrosion inhibiting pigment consisting of amorphous aluminum hydroxyl orthophosphate condensate dispersed within the binding polymer, wherein the amorphous aluminum hydroxyl orthophosphate has an oil absorption of less than 50; and wherein the coating composition comprises in the range of from 1 to 25 percent by weight of the amorphous aluminum hydroxyl orthophosphate, and wherein the coating composition provides a controlled delivery of phosphate anion in the range of from 50 to 500 ppm when the coating composition is in the form of a cured film, and wherein the coating composition has a total solubles content of from 50 to 800 ppm, wherein the total solubles content includes the phosphate anion. The amorphous aluminium phosphate is preferably free of alkali metals and alkaline earth metals and the coating composition has a water adsorption potential of up to 25% by weight water. The disclosure also related to a system of applying the coating composition to a metallic substrate.
Patent NZ-623416-A (NZ)
Title: Optical readable code support and capsule for preparing a beverage having such code support providing an enhanced readable optical signal
Inventor: GERBAULET ARNAUD
IPC: A47J31/44
Filed: 2012-11-08
Abstract: Disclosed is an optically readable code support (30) to be associated with or be part of a capsule indented for delivering a beverage in a beverage producing device by centrifugation of the capsule. The support comprising at least one sequence of binary symbols represented on the support so that each symbol is sequentially readable by a reading arrangement of an external reading device while the capsule is driven in rotation along an axis of rotation. The binary symbols are essentially formed of light reflective surfaces (400-403) and light absorbing surfaces (410-414). The code support preferably comprises a base structure (500) extending continuously at least along the sequence of symbols and discontinuous discrete light-absorbing portions (528) locally applied onto or formed at the surface of the base structure. The discontinuous discrete light-absorbing portions form the light- absorbing surfaces and the base structure (500) forms the light-reflective surfaces (400-403) outside the surface areas occupied by the discrete light-absorbing portions. The discrete light-absorbing portions (410-414) are arranged to provide a lower light-reflectivity than the one of the base structure outside the surface areas occupied by the discrete light-absorbing portions. The light-reflective base structure (500) comprises a monolithic metal support layer or polymeric support layer. The layer is coated by a lacquer comprising light-reflective particles.
Patent NZ-623615-A (NZ)
Title: Device for automatic injection of drug doses
Inventor: MOSELEY GUY CONWYN JULIAN
IPC: A61M5/315
Filed: 2012-09-06
Abstract: A device for the automatic injection of doses of a drug compound comprising a sliding sheath (30) which, when depressed with its front end (3) against the injection site, interacts with cam means to activate the triggering of a plunger, controlling the delivery of a drug dose. Plunger guide means (44) are provide for controlling the triggering sequence and means (4) for arming the device in the dose delivery condition. Automatic needle re-sheathing and resetting of a lock-out condition after each dose is delivered are provided. The number of the device components is reduced resulting in a simpler structure and cost reduction.
Patent NZ-625739-A (NZ)
Title: An air diffuser and an air circulation system
Inventor: BADENHORST SEAN MICHAEL JOHL
IPC: F24F13/26
Filed: 2012-12-05
Abstract: An air diffuser with a number of discharge elements (4a to 4d). The discharge elements are configured so that they can be arranged in the diffuser so as to abut and form a tessellation of discharge elements in a plane. At least one of the elements has a biasing mechanism. The biasing mechanism is configured to bias the at least one discharge element to form the tessellation of discharge elements into a plane. At least one of the discharge elements is able to be adjusted of the plane for adjustment of its orientation.
Patent NZ-707306-A (NZ)
Title: Magnetic separator
Inventor: ADEY CHRISTOPHER
IPC: F24D19/00
Filed: 2013-11-04
Abstract: A magnetic separator (10) for a central heating system which is more easily removable and replaceable from the water line, in particular by providing means for releasing two connectors at the same time. The invention includes a housing (12), a separation chamber within the housing (12), inlet and outlet ports (20, 20a) extending form the housing, the inlet and outlet ports including push- fit connectors (30) having collets surrounding the mouth of each of the inlet and outlet for releasing the connectors (30), and a release tool (44), the release tool (44) having first and second bearing areas (46, 48) for bearing against the collets of the inlet and outlet connectors (30), and a handle region (50, 52) for enabling force to be applied, via the bearing areas (46, 48), to both connectors simultaneously.
Patent NZ-709994-A (NZ)
Title: Process of producing a lactate ferment
Inventor: DIERDORP-ANDREAE BRENDA MARJA
IPC: A23L3/3535
Filed: 2014-01-15
Abstract: The present invention relates to fermentation processes. The objective of the invention was to provide methods for producing ferments and formulating such ferments into preservatives. It was in particular an object of the present invention to provide improved processes for producing lactic acid containing ferments by simple and efficient (batch) culturing and allowing for simple down-stream processing either into a liquid, semi-liquid or a dry powder product, having sufficient stability, good handling properties and satisfactory organoleptic properties. Such processes are provided, as well as the products that can be obtained with it and their use as food preservative.
Patent NZ-721540-A (NZ)
Title: Vermin control compositions
Inventor: GOODE STEVEN
IPC: A01N25/02
Filed: 2014-12-22
Abstract: A composition for killing an animal, e.g. a rodent, comprising: (i) a toxin component comprising one or more agents toxic to the animal, e.g. cholecalciferol or 25-hydroxycholecalciferol (vitamin D3); and (ii) a carrier system for the toxin component; wherein the carrier system (ii) comprises: (a) at least one solvent or dispersant for the toxin component, e.g. an alcohol such as ethanol, and (b) at least one dermal disruptant component, e.g. dimethylsulfoxide (DMSO). The compositions provide enhanced dermal penetration of the toxin into and through the skin of the animal onto which the composition is sprayed or delivered, e.g. in a trap or other apparatus.